Browsing Tag
Verici Dx
2 posts
Verici Dx (AIM: VRCI) secures £8.75m as investors confront major share dilution
Verici Dx has completed a £8.75 million fundraising and restored AIM trading, providing capital for commercial expansion while potentially leaving pre-fundraising shareholders with just 34.3% of the enlarged issued share capital.
October 14, 2026
Verici Dx signs licensing deal with Thermo Fisher for kidney rejection test
Verici Dx plc, a pioneer in clinical diagnostics for organ transplant, has announced an exclusive global licensing agreement…
November 16, 2023